EUCTR2007-002551-17-SE进行中（未招募）不适用
Randomised, double-blind, parallel-group, placebo-controlled, and active referenced study of Lu AA34893 to evaluate the efficacy and safety of three doses Lu AA34893 and quetiapine versus placebo in the treatment of depression in patients with Bipolar I or II Disorder
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •·The patient fulfils the DSM-IV-TR criteria of a current major depressive episode of Bipolar Disorder I or Bipolar Disorder II, lasting for at least 30 days before screening
- •·The patient has a documented history of at least one manic and/or hypomanic episode within the past 15 years.
- •·The patient has a MADRS total score of 26 or higher and a YMRS total score of 8 or less at screening and baseline visits.
- •·The patient is a man or woman, aged between 18 and 65 years (extremes included),
- •·The patient is an in-patient in a psychiatric hospital or an out-patient at a psychiatric setting.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •·Any current psychiatric disorder other than Bipolar Disorder established as the principal diagnosis as defined in the DSM-IV-TR or any current neurolgical disorder other than Bipolar Disorder
- •·Any substance disorder (except nicotine and caffeine) within the previous 6 months as defined in the DSM-IV-TR.
- •·The patient has a history of very rapid cycling
- •·The patient has, in the Investigator’s opinion, a significant risk of suicide
- •·The patient has received quetiapine in doses of 50mg/day or above as treatment during the current depressive episode
- •·The patient’s current depressive episode has been non-responsive to two or more adequate antidepressant treatments of at least 6 weeks duration
- •·The patient’s current depressive episode has been non-responsive to two or more antipsychotic treatments of at least 6 weeks duration
- •·The patient is currently treated or has been treated within 2 weeks prior to randomisation with one or more mood stabilisers, lamotrigine, anti-psychotic or antidepressive drugs.
- •The patient requires ECT or has received ECT within the last 6 months.
- •·The patient is currently receiving formal cognitive or behavioural therapy, systematic psychotherapy, or plans to initiate such therapy during the study.
研究者
相似试验
进行中（未招募）
1 期
Randomised, double-blind, parallel-group, placebo-controlled, duloxetine referenced, dose-finding study of Lu AA24530 in Major Depressive DisorderMedDRA version: 9.1Level: LLTClassification code 10057840Term: Major depressionMajor Depressive DisorderEUCTR2007-001071-11-SEH. Lundbeck A/S625
进行中（未招募）
1 期
Study of Lu AE58054 in Patients with Mild-moderate Alzheimer's disease treated with DonepezilAlzheimer´s DiseaseMedDRA version: 17.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852EUCTR2012-004764-22-HRH. Lundbeck A/S840
进行中（未招募）
1 期
Randomised, double-blind, parallel-group, placebo-controlled, duloxetine-referenced, fixed dose study comparing the efficacy and safety of Lu AA21004 in acute treatment of major depressive disorder in elderly patients - Not applicableEUCTR2008-002901-38-FIH. Lundbeck A/S450
进行中（未招募）
1 期
Study of Lu AE58054 in Patients With Mild-moderate Alzheimer's Disease Treated With DonepezilAlzheimer?s diseaseMedDRA version: 16.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852EUCTR2012-004763-45-ESH. Lundbeck A/S930
进行中（未招募）
不适用
Randomised, double-blind, parallel-group, placebo-controlled, fixed-dose comparison study of escitalopram in combination with two fixed doses of gaboxadol to escitalopram in Major Depressive DisorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSMajor Depressive DisorderEUCTR2008-000506-36-ATH. Lundbeck A/S500